Current and historical daily PE Ratio for Guangdong Hybribio Biotech Co Ltd (
SZSE:300639
) from 2017 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guangdong Hybribio Biotech stock (SZSE:300639) PE ratio as of May 22 2024 is 45.8.
More Details
Guangdong Hybribio Biotech Co Ltd (SZSE:300639) PE Ratio (TTM) Chart
Guangdong Hybribio Biotech Co Ltd (SZSE:300639) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 1188
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Guangdong Hybribio Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-22 | 45.8 | 2024-03-13 | 24.6 |
| 2024-05-21 | 45.9 | 2024-03-12 | 24.5 |
| 2024-05-20 | 46.8 | 2024-03-11 | 24.0 |
| 2024-05-17 | 46.8 | 2024-03-08 | 23.6 |
| 2024-05-16 | 46.3 | 2024-03-07 | 23.4 |
| 2024-05-15 | 46.3 | 2024-03-06 | 23.9 |
| 2024-05-14 | 47.6 | 2024-03-05 | 24.1 |
| 2024-05-13 | 47.9 | 2024-03-04 | 24.5 |
| 2024-05-10 | 49.7 | 2024-03-01 | 24.4 |
| 2024-05-09 | 51.2 | 2024-02-29 | 24.5 |
| 2024-05-08 | 51.1 | 2024-02-28 | 23.9 |
| 2024-05-07 | 50.2 | 2024-02-27 | 24.9 |
| 2024-05-06 | 49.5 | 2024-02-26 | 24.6 |
| 2024-04-30 | 47.8 | 2024-02-23 | 24.5 |
| 2024-04-29 | 47.9 | 2024-02-22 | 24.2 |
| 2024-04-26 | 47.3 | 2024-02-21 | 24.1 |
| 2024-04-25 | 46.3 | 2024-02-20 | 23.7 |
| 2024-04-24 | 44.8 | 2024-02-19 | 23.5 |
| 2024-04-23 | 46.3 | 2024-02-08 | 24.4 |
| 2024-04-22 | 45.6 | 2024-02-07 | 22.6 |
| 2024-04-19 | 46.6 | 2024-02-06 | 22.0 |
| 2024-04-18 | 47.7 | 2024-02-05 | 19.6 |
| 2024-04-17 | 49.1 | 2024-02-02 | 21.4 |
| 2024-04-16 | 46.6 | 2024-02-01 | 22.8 |
| 2024-04-15 | 48.9 | 2024-01-31 | 22.8 |
| 2024-04-12 | 51.7 | 2024-01-30 | 23.9 |
| 2024-04-11 | 52.8 | 2024-01-29 | 24.8 |
| 2024-04-10 | 53.5 | 2024-01-26 | 25.5 |
| 2024-04-09 | 54.7 | 2024-01-25 | 25.9 |
| 2024-04-08 | 52.9 | 2024-01-24 | 24.9 |
| 2024-04-03 | 55.6 | 2024-01-23 | 24.8 |
| 2024-04-02 | 56.0 | 2024-01-22 | 24.9 |
| 2024-04-01 | 56.6 | 2024-01-19 | 26.4 |
| 2024-03-29 | 53.9 | 2024-01-18 | 26.7 |
| 2024-03-28 | 53.4 | 2024-01-17 | 27.3 |
| 2024-03-27 | 23.1 | 2024-01-16 | 28.1 |
| 2024-03-26 | 23.4 | 2024-01-15 | 28.2 |
| 2024-03-25 | 23.7 | 2024-01-12 | 28.5 |
| 2024-03-22 | 24.8 | 2024-01-11 | 29.0 |
| 2024-03-21 | 25.0 | 2024-01-10 | 28.7 |
| 2024-03-20 | 25.1 | 2024-01-09 | 29.0 |
| 2024-03-19 | 24.7 | 2024-01-08 | 29.4 |
| 2024-03-18 | 24.9 | 2024-01-05 | 30.0 |
| 2024-03-15 | 24.5 | 2024-01-04 | 30.7 |
| 2024-03-14 | 24.4 | 2024-01-03 | 30.9 |
Guangdong Hybribio Biotech Co Ltd (SZSE:300639) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Guangdong Hybribio Biotech Co Ltd
ISIN : CNE100002N51
Share Class Description:
SZSE:300639: Class ACompare
Compare
Traded in other countries / regions
300639.China IPO Date
2017-04-12Description
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers